𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis

✍ Scribed by Shigeo Horiike; Masafumi Taniwaki; Shinichi Misawa; Tatsuo Abe


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
800 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Better prognosis for patients with del(7
✍ Iris Cordoba; JosΓ© R. GonzΓ‘lez-Porras; Benet Nomdedeu; Elisa LuΓ±o; Raquel de Paz πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 292 KB

## Abstract ## BACKGROUND: Abnormalities involving chromosome 7 are frequent in myelodysplastic syndrome (MDS) and suggest a poor prognosis. ## METHODS: The authors examined the hypothesis that the clinical features and survival associated with isolated deletion (del) of part of the long arm of

The prognosis for patients with chronic
✍ Michael W. N. Deininger; Jorge Cortes; Ron Paquette; Byung Park; Andreas Hochhau πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 380 KB

## Abstract ## BACKGROUND. Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)‐negative cells in some patients with chronic myeloid leukemia (CML) who attained a cytogenetic response to imatinib mesylate. In some patients, CCA/Ph‐negative status was associated with

Utility of blasts with a clear halo arou
✍ Iwao Emura; Takaaki Chou; Yosuke Imai; Toshio Kakihara; Keiko Asami; Makoto Nait πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 137 KB πŸ‘ 2 views

This study was designed to evaluate the utility of blasts with a clear halo around their nucleoli (BCHN) as a predictive indicator of disease progression in myelodysplastic syndromes (MDSs) and aplastic anemia (AA). Bone marrow aspirates from 75 patients with MDSs and 18 with AA were fixed in 95% et

Results of intensive chemotherapy in 998
✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Elderly patients (age β‰₯ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s